Fehlings M G, Tator C H, Linden R D
Canadian Paraplegic Association Spinal Cord Injury Research Laboratory, Toronto Western Hospital, Ontario.
J Neurosurg. 1989 Sep;71(3):403-16. doi: 10.3171/jns.1989.71.3.0403.
There is evidence that posttraumatic ischemia is important in the pathogenesis of acute spinal cord injury (SCI). In the present study spinal cord blood flow (SCBF), measured by the hydrogen clearance technique, and motor and somatosensory evoked potentials (MEP and SSEP) were recorded to evaluate whether the administration of nimodipine and dextran 40, alone or in combination, could increase posttraumatic SCBF and improve axonal function in the cord after acute SCI. Thirty rats received a 53-gm clip compression injury on the cord at T-1 and were then randomly and blindly allocated to one of six treatment groups (five rats in each). Each group was given an intravenous infusion of one of the following over 1 hour, commencing 1 hour after SCI: placebo and saline; placebo and dextran 40; nimodipine 0.02 mg/kg and saline; nimodipine 0.02 mg/kg and dextran 40; nimodipine 0.05 mg/kg and saline; and nimodipine 0.05 mg/kg and dextran 40. The preinjury physiological parameters, including the SCBF at T-1 (mean +/- standard error of the mean: 56.84 +/- 4.51 ml/100 gm/min), were not significantly different (p greater than 0.05) among the treatment groups. Following SCI, there was a significant decrease in the SCBF at T-1 (24.55 +/- 2.99 ml/100 gm/min; p less than 0.0001) as well as significant changes in the MEP recorded from the spinal cord (MEP-C) (p less than 0.0001), the MEP recorded from the sciatic nerve (MEP-N) (p less than 0.0001), and the SSEP (p less than 0.002). Only the combination of nimodipine 0.02 mg/kg and dextran 40 increased the SCBF at T-1 (43.69 +/- 6.09 ml/100 gm/min; p less than 0.003) and improved the MEP-C (p less than 0.0001), MEP-N (p less than 0.04), and SSEP (p less than 0.002) following SCI. With this combination, the changes in SCBF were significantly related to improvement in axonal function in the motor tracts (p less than 0.0001) and somatosensory tracts (p less than 0.0001) of the cord. This study provides quantitative evidence that an increase in posttraumatic SCBF can significantly improve the function of injured spinal cord axons, and strongly implicates posttraumatic ischemia in the pathogenesis of acute SCI.
有证据表明创伤后缺血在急性脊髓损伤(SCI)的发病机制中起重要作用。在本研究中,采用氢清除技术测量脊髓血流量(SCBF),并记录运动和体感诱发电位(MEP和SSEP),以评估单独或联合使用尼莫地平和右旋糖酐40是否能增加急性SCI后创伤后的SCBF并改善脊髓中的轴突功能。30只大鼠在T-1水平接受53克夹压损伤脊髓,然后随机且盲法分配到六个治疗组之一(每组五只大鼠)。在SCI后1小时开始,每组在1小时内静脉输注以下其中一种:安慰剂和生理盐水;安慰剂和右旋糖酐40;0.02毫克/千克尼莫地平和生理盐水;0.02毫克/千克尼莫地平和右旋糖酐40;0.05毫克/千克尼莫地平和生理盐水;以及0.05毫克/千克尼莫地平和右旋糖酐40。损伤前的生理参数,包括T-1水平的SCBF(平均值±平均标准误差:56.84±4.51毫升/100克/分钟),在各治疗组之间无显著差异(p>0.05)。SCI后,T-1水平的SCBF显著下降(24.55±2.99毫升/100克/分钟;p<0.0001),同时脊髓记录的MEP(MEP-C)(p<0.0001)、坐骨神经记录的MEP(MEP-N)(p<0.0001)和SSEP(p<0.002)也有显著变化。只有0.02毫克/千克尼莫地平和右旋糖酐40的组合增加了SCI后T-1水平的SCBF(43.69±6.09毫升/100克/分钟;p<0.003),并改善了MEP-C(p<0.0001)、MEP-N(p<0.04)和SSEP(p<0.002)。使用该组合时,SCBF的变化与脊髓运动束(p<0.0001)和体感束(p<0.0001)轴突功能的改善显著相关。本研究提供了定量证据表明创伤后SCBF的增加可显著改善受损脊髓轴突的功能,并有力地表明创伤后缺血在急性SCI的发病机制中起作用。